Search

A phase 3 trial for myelofibrosis found that adding pelabresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.

… Tuesday, April 29, 2025 An international phase 3 clinical trial of a new drug combination for treating the blood cancer  myelofibrosis found that adding a second, experimental drug to standard treatment was more effective than the standard treatment alone. Further, adding the second drug did not significantly

New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain.

… Thursday, February 27, 2014 New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the February 27 issue of Cell , the study found that tumor cells that reach the brain — and successfully

Minimally invasive techniques, improved postoperative care, and a multidisciplinary approach help make Memorial Sloan Kettering Cancer Center’s rates of esophageal surgical morbidity and mortality among the country’s lowest.

… Friday, September 23, 2016 At Memorial Sloan Kettering Cancer Center (MSK), we have made significant strides in the management of esophageal cancer over the past ten years. Improvements in postoperative care and the introduction of minimally invasive techniques have decreased the number of postoperative

The Lehigh Valley Health Network (LVHN) Cancer Institute is now a formal member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for people with cancer in community healthcare settings. Representatives of both organizations made the announcement today at Lehigh Valley Hospital–Cedar Crest following an intensive six-month collaborative review process.

… Tuesday, March 15, 2016 The Lehigh Valley Health Network (LVHN) Cancer Institute is now a formal member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for people with cancer in community healthcare settings. Representatives

Learn about a heartburn-related condition called Barrett’s esophagus and its connection to a higher risk of esophageal cancer.

… Friday, July 10, 2020 Summary People with chronic heartburn may have gastroesophageal reflux disease . This can develop into a condition called Barrett’s esophagus , which increases the risk of esophageal cancer. Barrett’s esophagus should be closely monitored, and in some cases treated, to reduce this

Prognostic genetic testing is recommended for all patients with chronic lymphocytic leukemia (CLL). However, recent research shows that testing is infrequently performed and outcomes poorer in patients with unfavorable disease risk.

… Tuesday, July 10, 2018 Prognostic genetic testing is recommended for all patients with chronic lymphocytic leukemia (CLL) to inform disease management and predict survival and disease progression. However, recent research shows that among almost 1,500 patients with CLL who were treated in a community

By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.

… Thursday, May 12, 2022 Daniel Heller holding a model of a nanosensor Biomedical engineer Daniel Heller leads the Cancer Nanomedicine Laboratory at MSK. Mijin Kim Kravis WiSE Postdoctoral Fellow Mijin Kim MSK surgeon Kara C. Long MSK surgeon Kara C. Long Lakshmi Ramanathan Lakshmi Ramanathan, Chief of

Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their latest research at the 65th American Society of Hematology (ASH) Annual Meeting, held in San Diego, December 9 to 12, 2023.

… Monday, December 11, 2023 Memorial Sloan Kettering Cancer Center (MSK) experts shared the results of their latest research at the 65 th American Society of Hematology (ASH) Annual Meeting, held in San Diego, December 9 to 12, 2023. Highlights included essential insights into managing and reducing treatment-related

Learn about 14 students who will receive doctoral degrees from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at MSK.

… Tuesday, May 28, 2019 Summary This week 14 students will receive doctoral degrees from the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences at Memorial Sloan Kettering (MSK). They are the largest group to graduate in a given year since the school was established in 2004. The innovative program

… Sunday, September 30, 2007 This summer we witnessed young scientists at various crossroads in their careers. Our inaugural class of PhD students completed their first year of study and took the important step of choosing their thesis laboratories. We welcomed our second class of PhD students, who, at